
Cellarity
@cellaritybio
Founded by @FlagshipPioneer, Cellarity is developing medicines through an understanding of cell behaviors.
ID: 1094704193728901122
https://www.cellarity.com 10-02-2019 21:06:33
203 Tweet
1,1K Followers
479 Following



Our CEO Fabrice Chouraqui spoke with Drug Target Review to explain how Cellarity is using #AI and #MachineLearning to predict and prevent drug toxicity, potentially reducing treatment costs. More: bit.ly/4cfeODT



Our CEO Fabrice Chouraqui explains the power of our drug discovery platform in a new interview with Pharmaceutical Executive. Listen here: bit.ly/3WegtTc

We’re focusing on the whole cell to transform drug discovery. Hear from our CEO Fabrice Chouraqui on Pharmaceutical Executive about our drug candidate with gene-therapy-like efficacy in a once-daily pill to treat sickle cell disease: bit.ly/4cO02UL

Our CEO Fabrice Chouraqui & The Medicine Maker discuss how Cellarity’s platform uses #AI and #ML to re-envision #DrugDiscovery & the impact approaches like ours could have on people living with disease and in need of new therapies. Read the Q&A: bit.ly/4cF3AYQ

Cellarity CEO Fabrice Chouraqui joins Biotech2050 Podcast's Rahul Chaturvedi to discuss his career journey, and the shared language and mindset of our teams working to harness #AI and #MachineLearning to bring innovative medicines to patients. 🎙️ Listen: open.spotify.com/episode/71uPMq…

Our CEO Fabrice Chouraqui tells Pharmaceutical Executive how our cutting-edge platform is transforming the treatment of MASH in partnership with Novo Nordisk. The future of medicine is here, and our platform is leading the way. Learn more: bit.ly/3WeCjpM



Attend #medSCAI24—our 3rd annual symposium on medicines, single cell tech & #AI! Join leaders for two sessions on AI & #MachineLearning-powered #DrugDiscovery. Featuring Arpeggio Biosciences, MIT Dept of BE, UW Genome Sciences, Novartis & more. Register ➡️ bit.ly/3yOdJEL


Thrilled to announce our #medSCAI24 panel on realizing AI's full translational impact on drug development. Register ➡️ bit.ly/3yOdJEL Ryan Cross the Science Boss, 1910 Genetics, NVIDIA, Novo Nordisk, Novartis



Our Chief Medical Officer Cameron Trenor spoke with PharmaVoice to discuss challenges facing #SickleCell disease treatments and how Cellarity is approaching a new option for patients. 🔗More at bit.ly/3YZS3PY #SCD #BiggerLeaps

